Tg(APOC3)2721Bres
Transgene Detail
|
Symbol: |
Tg(APOC3)2721Bres |
Name: |
transgene insertion 2721, Jan L Breslow |
MGI ID: |
MGI:3703621 |
Synonyms: |
G1, High exp (2721), high expressor, Tg line 2721 |
Transgene: |
Tg(APOC3)2721Bres Location: unknown
|
Alliance: |
Tg(APOC3)2721Bres page
|
|
Strain of Origin: |
(C57BL/6J x CBA/J)F2
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(APOC3)2721Bres expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APOC3 (345) |
|
|
|
|
|
Mutation details: Male pronuclei of fertilized oocytes were microinjected with a transgenic construct comprising the human apolipoprotein C-III gene, including 2.5 kb of 5' and 1.1 kb of 3' flanking sequence. 100-110 copies of the transgene were estimated present per haploid genome by quantitative Southern blot analysis. Solution hybridization RNase protection analysis with a riboprobe representing the 3' untranslated region of human APOC3 demonstrated high levels of transgene-derived RNA in liver and lower levels in intestine, but none in brain of transgenic mice. Electroimmunoanalysis with a human-specific anti-APOC3 antibody detected human APOC3 at 54 +/- 11 mg/dl in plasma of transgenic mice.
(J:81184)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:81184 Ito Y, et al., Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990 Aug 17;249(4970):790-3 |
All: |
5 reference(s) |
|